
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
CHSY1 promotes CD8+ T cell exhaustion through activation of succinate metabolism pathway leading to colorectal cancer liver metastasis based on CRISPR/Cas9 screening
Guangshun Sun, Siqi Zhao, Zhongguo Fan, et al.
Journal of Experimental & Clinical Cancer Research (2023) Vol. 42, Iss. 1
Open Access | Times Cited: 22
Guangshun Sun, Siqi Zhao, Zhongguo Fan, et al.
Journal of Experimental & Clinical Cancer Research (2023) Vol. 42, Iss. 1
Open Access | Times Cited: 22
Showing 22 citing articles:
Mechanism insights and therapeutic intervention of tumor metastasis: latest developments and perspectives
Xiaoli Shi, Xinyi Wang, Wentao Yao, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 21
Xiaoli Shi, Xinyi Wang, Wentao Yao, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 21
CRISPR–Cas9 applications in T cells and adoptive T cell therapies
Xiaoying Chen, Shuhan Zhong, Yonghao Zhan, et al.
Cellular & Molecular Biology Letters (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 10
Xiaoying Chen, Shuhan Zhong, Yonghao Zhan, et al.
Cellular & Molecular Biology Letters (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 10
Finding a needle in a haystack: functional screening for novel targets in cancer immunology and immunotherapies
Yi Du, Yang Yang, Bohao Zheng, et al.
Oncogene (2025)
Open Access
Yi Du, Yang Yang, Bohao Zheng, et al.
Oncogene (2025)
Open Access
Tumor Metastasis: Mechanistic Insights and Therapeutic Intervention
Lin Tang, Peng Shen, Xiaoying Zhuang, et al.
MedComm – Oncology (2025) Vol. 4, Iss. 1
Open Access
Lin Tang, Peng Shen, Xiaoying Zhuang, et al.
MedComm – Oncology (2025) Vol. 4, Iss. 1
Open Access
Liver Metastasis in Cancer: Molecular Mechanisms and Management
Wenchao Xu, Jia Xu, Jianzhou Liu, et al.
MedComm (2025) Vol. 6, Iss. 3
Open Access
Wenchao Xu, Jia Xu, Jianzhou Liu, et al.
MedComm (2025) Vol. 6, Iss. 3
Open Access
Liver Extracellular Matrix in Colorectal Liver Metastasis
Marika Morabito, Pauline Thibodot, Anthony Gigandet, et al.
Cancers (2025) Vol. 17, Iss. 6, pp. 953-953
Open Access
Marika Morabito, Pauline Thibodot, Anthony Gigandet, et al.
Cancers (2025) Vol. 17, Iss. 6, pp. 953-953
Open Access
Immunomodulatory Molecules in Colorectal Cancer Liver Metastasis
W. Kong, Jia-Jun Li, Yuqing Deng, et al.
Cancer Letters (2024) Vol. 598, pp. 217113-217113
Closed Access | Times Cited: 4
W. Kong, Jia-Jun Li, Yuqing Deng, et al.
Cancer Letters (2024) Vol. 598, pp. 217113-217113
Closed Access | Times Cited: 4
Metabolic gatekeepers: harnessing tumor-derived metabolites to optimize T cell-based immunotherapy efficacy in the tumor microenvironment
Yucheng Zheng, Rongwei Xu, Xu Chen, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 10
Open Access | Times Cited: 4
Yucheng Zheng, Rongwei Xu, Xu Chen, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 10
Open Access | Times Cited: 4
Artemisinin and Its Derivatives as Potential Anticancer Agents
L Y Wen, Ben Chung-Lap Chan, Ming‐Hua Qiu, et al.
Molecules (2024) Vol. 29, Iss. 16, pp. 3886-3886
Open Access | Times Cited: 3
L Y Wen, Ben Chung-Lap Chan, Ming‐Hua Qiu, et al.
Molecules (2024) Vol. 29, Iss. 16, pp. 3886-3886
Open Access | Times Cited: 3
Immune dynamics shaping pre-metastatic and metastatic niches in liver metastases: from molecular mechanisms to therapeutic strategies
Chang Zhu, J Liao, Yiyang Liu, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 2
Chang Zhu, J Liao, Yiyang Liu, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 2
Development of an anoikis-related gene signature and prognostic model for predicting the tumor microenvironment and response to immunotherapy in colorectal cancer
Chuanchang Li, Junyong Weng, Le Yang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Chuanchang Li, Junyong Weng, Le Yang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Application of Traditional Chinese Medicine in Inhibiting the PD-1/PD-L1 Pathway in the Treatment of Gastric and Colon Cancers
Xinghui Zhu, ShuJie Wang, Lie Wen Xie, et al.
Natural Product Communications (2024) Vol. 19, Iss. 6
Open Access | Times Cited: 1
Xinghui Zhu, ShuJie Wang, Lie Wen Xie, et al.
Natural Product Communications (2024) Vol. 19, Iss. 6
Open Access | Times Cited: 1
Therapeutic targets for hepatocellular carcinoma identified using proteomics and Mendelian randomization
Weixiong Zhu, Chuanlei Fan, Bo Liu, et al.
Journal of Gastroenterology and Hepatology (2024)
Closed Access | Times Cited: 1
Weixiong Zhu, Chuanlei Fan, Bo Liu, et al.
Journal of Gastroenterology and Hepatology (2024)
Closed Access | Times Cited: 1
High-throughput screening for optimizing adoptive T cell therapies
Yuchen Zhang, Qinglong Xu, Zhifei Gao, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 1
Yuchen Zhang, Qinglong Xu, Zhifei Gao, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 1
Nano Strategies for Artemisinin Derivatives to Enhance Reverse Efficiency of Multidrug Resistance in Breast Cancer
Xueyan Zhang, Na Li, Guoqin Zhang, et al.
Current Pharmaceutical Design (2023) Vol. 29, Iss. 43, pp. 3458-3466
Closed Access | Times Cited: 4
Xueyan Zhang, Na Li, Guoqin Zhang, et al.
Current Pharmaceutical Design (2023) Vol. 29, Iss. 43, pp. 3458-3466
Closed Access | Times Cited: 4
Genome-wide CRISPR Screening Identifies the Pivotal Role of ANKRD42 in Colorectal Cancer Metastasis Through EMT Regulation
Shengde Liu, Zizhen Zhang, Zhenghang Wang, et al.
Research Square (Research Square) (2024)
Open Access
Shengde Liu, Zizhen Zhang, Zhenghang Wang, et al.
Research Square (Research Square) (2024)
Open Access
Metabolomics Research on Treatment of Primary Liver Cancer with Cortex Juglandis Mandshuricae on LC-MS/MS Technology
Taowen Pan, Xiaoli Shi, Yong-Rui Bao, et al.
(2024)
Closed Access
Taowen Pan, Xiaoli Shi, Yong-Rui Bao, et al.
(2024)
Closed Access
The prognostic implications and tumor-promoting functions of CHSY3 in gastric cancer
Han Wang, Junchang Zhang, Zhuoqi Wei, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Han Wang, Junchang Zhang, Zhuoqi Wei, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Genome‐wide CRISPR screening identifies the pivotal role of ANKRD42 in colorectal cancer metastasis through EMT regulation
Shengde Liu, Zizhen Zhang, Zhenghang Wang, et al.
IUBMB Life (2024) Vol. 76, Iss. 10, pp. 803-819
Open Access
Shengde Liu, Zizhen Zhang, Zhenghang Wang, et al.
IUBMB Life (2024) Vol. 76, Iss. 10, pp. 803-819
Open Access
Identification of an inflammatory response-related gene prognostic signature and immune microenvironment for cervical cancer
Zhuna Wu, Xuanxuan Zhuang, Мейли Лианг, et al.
Frontiers in Molecular Biosciences (2024) Vol. 11
Open Access
Zhuna Wu, Xuanxuan Zhuang, Мейли Лианг, et al.
Frontiers in Molecular Biosciences (2024) Vol. 11
Open Access
Metabolomics Research on Treatment of Primary Liver Cancer with Cortex Juglandis Mandshuricae on LC-MS/MS Technology
Taowen Pan, Xiaoli Shi, Yong-Rui Bao, et al.
Journal of Pharmaceutical and Biomedical Analysis (2024) Vol. 248, pp. 116320-116320
Closed Access
Taowen Pan, Xiaoli Shi, Yong-Rui Bao, et al.
Journal of Pharmaceutical and Biomedical Analysis (2024) Vol. 248, pp. 116320-116320
Closed Access
Reversal of T-cell exhaustion: Mechanisms and synergistic approaches
Yang Hu, Yaqi Zhang, Fenfen Shi, et al.
International Immunopharmacology (2024) Vol. 138, pp. 112571-112571
Closed Access
Yang Hu, Yaqi Zhang, Fenfen Shi, et al.
International Immunopharmacology (2024) Vol. 138, pp. 112571-112571
Closed Access
AK7-deficiency reversal inhibits ccRCC progression and boosts anti-PD1 immunotherapy sensitivity
Yigang Jin, Minjie Chen, Fei Chen, et al.
Aging (2024)
Open Access
Yigang Jin, Minjie Chen, Fei Chen, et al.
Aging (2024)
Open Access